TEL AVIV STOCK EXCHANGE · INCR
+32.34% · +$0.2810 · Vol 2.9M
Market closed · last close 4:00 PM ET · price as of 19:49:56 ET
InterCure Ltd

InterCure Ltd

Pharmaceuticals
$1.15
Card
Relationship Map

Veridion Score

BETALOW CONF · 6/6 factorsMethodology
INCR
InterCure Ltd
Fri Aug 21 · last completed session · Markets closed · resumes Mon 9:30 ET
NEUTRAL

Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.

59/ 100
Veridion Score
NEUTRAL · LOW confidence
Sovereign · $25/mo
See why this score moved.
  • · Factor breakdown with raw signals
  • · Day-over-day delta + driver
  • · Factor coverage readout
  • · Valuation · hype · market flow
  • · Pro Chart event markers
  • · Score history + alerts
Start Sovereign · $25/mo →
Cancel anytime · or Reserve · $79/mo
Confidence: LOW · 6/6 factors with data · Fri Aug 21 · last completed session · Markets closed · resumes Mon 9:30 ET
Share on X →
Veridion Score History · 90D
Loading score history
AI Analysis
Sovereign

Why is INCR moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Loading INCR catalysts
About InterCure Ltd
Pharmaceuticals
Listed since
2019
Employees
285
Country
IL

Intercure Ltd is engaged in the research, cultivation, production, and distribution of pharma-grade cannabis-based products. Its products are available in dried inflorescences or liquid oil form, and are marketed through various brands, including Pharmo Cann, Humboldt, Indoor, Space Labs, Canndoc Utopia, Binske, Canndoc Stars, and others. The company has two operating segments, namely Investments in portfolio companies in the biomed sector and Investments in the medical cannabis sector. A majority of its revenue is generated from the Cannabis segment.

Company website →
Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$0.8800
Day high
$0.8800
Day low
$0.8515
Previous close
$0.8690
52W high
$8.40
-86.31% from high
52W low
$0.8515
4% of range
Market cap
$10.1M
EPS
$-0.7700
Beta
1.76
Shares out
11.8M
Volume
2.9M
129.52× rel vol
Avg volume
22.6K
VWAP
$1.20
Price history computed in-house
1W
-75.73%
1M
-76.19%
3M
-74.60%
1Y
-86.31%
YTD
-74.73%
SMA 50 $4.82 · below
SMA 200 $4.89 · below
52W position 4%

INCR overview

Veridion Score
59
Registered · 2026-08-21
6 of 6 factors measured
Latest receipt rows
0
No recent disclosure on file.
13F holders
None on file

Related filings and maps

Relationship mapTrace receipt-backed holders and filings around INCR.Congress trackerSearch the public STOCK Act disclosure ledger.MethodologyReview score inputs, coverage rules, and limitations.
Loading financial statements
Loading INCR Form 4 filings
Public disclosures

Congress activity in INCR

Congress trackerOpen ticker disclosure ledger →

No receipt-qualified Congressional disclosure is present for INCR in the cached public ledger.

Federal contracts

INCR contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for INCR in this window.
Lobbying spend

INCR lobbying filings, year to date.

Registered lobbying filings matched to InterCure Ltd.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for INCR in this window.
Loading news for INCR
Analyst ratings
Sovereign unlock shows live analyst consensus for INCR.
Options
Sovereign unlock shows live options positioning for INCR.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.